Prellis Biologics Appoints New CEO, Raises $35 Million in Series C Funding to Leverage Human Immune System Biology to De-Risk and Accelerate Therapeutics Drug Discovery and Development
by dakota@oneupdigitalmarketing.com | Aug 10, 2022 | Uncategorized | 0 comments